Prostate cancer diagnosis and management across twenty years of clinical practice: a single-center experience on 2,500 cases
P Pepe, M Pennisi - Anticancer Research, 2019 - ar.iiarjournals.org
Background/Aim: To evaluate the diagnosis and management of prostate cancer (PCa)
across twenty years of clinical practice. Materials and Methods: From January 2000 to …
across twenty years of clinical practice. Materials and Methods: From January 2000 to …
[HTML][HTML] Current clinical challenges in prostate cancer
JL Silberstein, SK Pal, B Lewis… - … andrology and urology, 2013 - ncbi.nlm.nih.gov
Prostate cancer is the most common malignancy and the second leading cause of cancer
death in men in the United States. Close to $12 billion are spent annually on the treatment of …
death in men in the United States. Close to $12 billion are spent annually on the treatment of …
Therapeutic options in locally defined or advanced prostate cancer
JE Altwein - European urology, 1998 - karger.com
Objective: Critical discussion of the available therapeutic options in locally defined or
advanced prostate cancer (PCa) in the absence of standards or guidelines. Methods …
advanced prostate cancer (PCa) in the absence of standards or guidelines. Methods …
Advances in prostate cancer
CJ Ryan, EJ Small - Current opinion in oncology, 2004 - journals.lww.com
The data reported in the past year have widespread implications for all clinicians involved in
the management of prostate cancer, ranging from primary care physicians who screen for …
the management of prostate cancer, ranging from primary care physicians who screen for …
[HTML][HTML] Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions
In the early twenty-first century, societies around the world are facing the paradoxal
epidemic development of PCa as a non-communicable disease. PCa is the most frequently …
epidemic development of PCa as a non-communicable disease. PCa is the most frequently …
[HTML][HTML] Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Background In advanced prostate cancer (APC), successful drug development as well as
advances in imaging and molecular characterisation have resulted in multiple areas where …
advances in imaging and molecular characterisation have resulted in multiple areas where …
Localized prostate cancer
EA Klein, PA Kupelian - Current Treatment Options in Oncology, 2000 - Springer
Opinion statement Much controversy still surrounds the diagnosis and treatment of localized
prostate cancer. Urologists generally believe that early detection and aggressive surgical …
prostate cancer. Urologists generally believe that early detection and aggressive surgical …
[BOOK][B] Prostate Cancer: A Multidisciplinary Approach to Diagnosis and Management
CR Thomas Jr - 2014 - books.google.com
" This book admirably covers prostate cancer. It is written in an easily digestible manner for
non-experts and emphasizes the importance of a team approach to treatment of patients …
non-experts and emphasizes the importance of a team approach to treatment of patients …
United in Fight against prostate cancer registry (UFO): first results from a large, multi-center, prospective, longitudinal cohort study in Asia
H Uemura, D Ye, R Kanesvaran, H Zeng… - Annals of …, 2018 - annalsofoncology.org
Background: The way in which prostate cancer (PC) is diagnosed and treated is fragmented
across some Asian countries. We have established a PC registry (UFO) with the aim of …
across some Asian countries. We have established a PC registry (UFO) with the aim of …
[HTML][HTML] Current and future management of locally advanced and metastatic prostate cancer
ND Shore - Reviews in Urology, 2020 - ncbi.nlm.nih.gov
With increasing treatment options available, the management of locally advanced and
metastatic prostate cancer (PCa) is growing more complex, nuanced, and individualized …
metastatic prostate cancer (PCa) is growing more complex, nuanced, and individualized …